[212Pb]Pb-AG1002

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug Name[212Pb]Pb-AG1002
Drug Alias Name[212Pb]Pb-AG1002AG1002AG-1002
ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionSomatostatin receptor 2 binders
TargetsSomatostatin receptor 2
Therapy Area/IndicationsSolid tumoursNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai AlphaGen Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai AlphaGen Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A